Red yeast rice (monacolin K)
Fermented rice product containing monacolin K, chemically identical to lovastatin, with strong LDL-lowering RCT signal and statin-equivalent safety profile.
Why
Red yeast rice (Monascus purpureus fermented rice) contains monacolin K, a natural HMG-CoA reductase inhibitor structurally and functionally identical to the prescription statin lovastatin. Meta-analyses report LDL reductions of 15–25% at clinically used doses, comparable to low-dose statin monotherapy. Because the active is a statin in everything but name, safety considerations are the same, myopathy, rhabdomyolysis case reports, liver enzyme elevation, and statin drug interactions all apply. EFSA in 2022 set a strict limit of <3 mg monacolin K/day in food supplements; medicinal product registration is required above that.
How it works
Monacolin K inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis, increasing LDL-receptor expression and clearance of circulating LDL. Identical pharmacology to lovastatin.
Expected onset · LDL changes over 6–8 weeks
How to take
Dosage
EFSA-permitted: <3 mg monacolin K/day from food supplements. Historical RCT doses delivered 5–10 mg monacolin K/day under medicinal regulation. Always with a clinician.
Timing
Once daily with evening meal
On the label
Stated monacolin K content per serving (EFSA limit <3 mg/day). Certified citrinin-free. Treat as a medication, not a casual supplement.
Ideal for
Adults with mild-moderate hypercholesterolaemia who decline a pharmaceutical statin, after specialist evaluation, not for self-management without clinical supervision.
Safety
Evidence
Gerards 2015 Atherosclerosis meta-analysis (20 RCTs, n=6,663): red yeast rice reduced LDL by 1.02 mmol/L (~25%) vs placebo, comparable to low-dose statin monotherapy. Becker 2009 Ann Intern Med RCT in statin-intolerant patients confirmed LDL reduction with red yeast rice. EFSA's 2018 opinion led to the 2022 regulation limiting OTC sale to <3 mg monacolin K/day, practical reflection of the statin-equivalent pharmacology.
- Becker et al., Ann Intern Med 2009, red yeast rice for dyslipidemia in statin-intolerant patients (RCT)
- Gerards et al., Atherosclerosis 2015, traditional Chinese lipid-lowering agent red yeast rice for hypercholesterolaemia: meta-analysis
- EFSA NDA Panel, EFSA J 2018, scientific opinion on safety of monacolins in red yeast rice
Where to get it
Shop Red yeast rice (monacolin K) on AmazonSponsored · As an Amazon Associate, Healicus earns from qualifying purchases.